Literature DB >> 3413073

Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79.

E Y Lee1, R Bookstein, L J Young, C J Lin, M G Rosenfeld, W H Lee.   

Abstract

Formation of retinoblastoma, a cancer arising in the retinas of young children, is determined by mutational inactivation of an autosomal gene (RB), which has been molecularly cloned. Whereas all normal tissues and many tumor cells express an RB mRNA of 4.7 kilobases, six of six retinoblastomas were previously found either to lack RB gene expression or to have RB transcripts of abnormal (reduced) length. To further characterize the latter type of mutation, we chose to examine retinoblastoma cell line Y79, which expressed a shortened RB mRNA of about 4.0 kilobases. RB cDNA clones isolated from a library constructed with Y79 mRNA demonstrated an internal loss of 470 nucleotides near the 5' end, which corresponded to a deletion of exons 2-6. Genomic clones containing the deletion junction were isolated from a library made with Y79 DNA, which allowed precise localization and sequencing of deletion endpoints in introns 1 and 6. These regions had no apparent homology to each other or to the Alu family of repetitive sequences, implying that the deletion must have occurred by a mechanism other than recombination of homologous sequences. Deletion of exons 2-6 would interrupt the open reading frame in RB mRNA and would result in premature termination of translation. Since no normal RB protein was detected by immunoprecipitation with specific antibody, the other, apparently normal RB allele in Y79 cells was necessarily inactivated by a different mutation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3413073      PMCID: PMC281896          DOI: 10.1073/pnas.85.16.6017

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Retinoblastoma and chromosome 13.

Authors:  U Francke
Journal:  Birth Defects Orig Artic Ser       Date:  1976

2.  Characteristics of an established cell line of retinoblastoma.

Authors:  T W Reid; D M Albert; A S Rabson; P Russell; J Craft; E W Chu; T S Tralka; J L Wilcox
Journal:  J Natl Cancer Inst       Date:  1974-08       Impact factor: 13.506

3.  Characterization of a new continuous cell line derived from a human retinoblastoma.

Authors:  R C McFall; T W Sery; M Makadon
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

4.  Hereditary retinoblastoma: delayed mutation or host resistance?

Authors:  E Matsunaga
Journal:  Am J Hum Genet       Date:  1978-07       Impact factor: 11.025

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Retinoblastoma and subband deletion of chromosome 13.

Authors:  J J Yunis; N Ramsay
Journal:  Am J Dis Child       Date:  1978-02

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 8.  Genetics of retinoblastoma.

Authors:  F Vogel
Journal:  Hum Genet       Date:  1979-11-01       Impact factor: 4.132

9.  Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants.

Authors:  R Bookstein; E Y Lee; H To; L J Young; T W Sery; R C Hayes; T Friedmann; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  14 in total

1.  Molecular studies of deletions at the human steroid sulfatase locus.

Authors:  L J Shapiro; P Yen; D Pomerantz; E Martin; L Rolewic; T Mohandas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Molecular analysis of two mouse dilute locus deletion mutations: spontaneous dilute lethal20J and radiation-induced dilute prenatal lethal Aa2 alleles.

Authors:  M C Strobel; P K Seperack; N G Copeland; N A Jenkins
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

3.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.

Authors:  J Y Shew; B T Lin; P L Chen; B Y Tseng; T L Yang-Feng; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Cloning and sequence of the rat retinoblastoma (Rb) gene cDNA.

Authors:  N K Roy; A Ballesteros; S J Garte
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

5.  Molecular etiology of low-penetrance retinoblastoma in two pedigrees.

Authors:  T P Dryja; J Rapaport; T L McGee; T M Nork; T L Schwartz
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

6.  Mutations in the RB1 gene and their effects on transcription.

Authors:  J M Dunn; R A Phillips; X Zhu; A Becker; B L Gallie
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

7.  Human retinoblastoma gene: long-range mapping and analysis of its deletion in a breast cancer cell line.

Authors:  R Bookstein; E Y Lee; A Peccei; W H Lee
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

8.  Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product.

Authors:  J A Pietenpol; K Münger; P M Howley; R W Stein; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  Structure of the human retinoblastoma gene.

Authors:  F D Hong; H J Huang; H To; L J Young; A Oro; R Bookstein; E Y Lee; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Tumorspheres but not adherent cells derived from retinoblastoma tumors are of malignant origin.

Authors:  Wesley S Bond; Patricia Y Akinfenwa; Laszlo Perlaky; Mary Y Hurwitz; Richard L Hurwitz; Patricia Chévez-Barrios
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.